Block 1 Pharmacokinetics Flashcards
Pharmacokinetices domains
Absorption
Distribution
Metabolism (biotransformation)
Excretion
Enteral administration
GI tract: oral (PO), sublingual (SL), rectal (PR)
Pros & cons to enteral drug administration routes
PO: most convenient, safe, economical; variable absorption, irritation of GI, first-pass effect
SL: bypasses hepatic portal vein
PR: bypasses hepatic portal vein
Parenteral administration
Intravenous (IV), intramuscular (IM), subcutaneous (SC)
Pros & cons to parenteral drug admin routes
IV: immediate, emergency use, bypass GI, large volume; risk of adverse effects, training
IM: prompty, bypass GI, self-admin; limited volume, pain
SC: same as IM
Other routes of drug admin
Topical, transdermal (into systemic circulation), intra-arterial, intrathecal (into CNS), inhalation
Absorption of drugs
Lipid bilayer = polar/ionized harder to get across *Passive diffusion (depends on conc grad) Active transport (link transport proteins)
Transport proteins
Across epi -> intestine; OATP, p-glycoprotein (prevents absorption)
Ion trapping & gastric and plasma pH
Only non-ionized can pass lipid membranes
GI: 1.4
Plasma: 7.4
pKa of a drug
pH value at which ½ drug is ionized
Weak acid vs. weak base
WA: low pKa, diffusion at low pH, blocked at high pH
WB: high pKa, diffusion at high pH, blocked at low pH
Factors affecting oral absorption
Dosage formulations: enteric coating (dissolves at high pH), controlled release (for short T½)
Blood flow: poor absorption with shock, short bowel syndrome
GI motility: inc or dec contact time with drugs
First pass effect: metabolism by liver
Causes of inc and dec GI motility
Inc: diarrhea, laxative
Dec: diabetes, anticholinergic drugs
Bioavailability
F = fraction entering systemic circulation (100% for parenteral drugs)
Low oral F for drugs subject to first-pass effect
First-pass effect
Drugs absorbed from GI metabolized by liver before reaching systemic circulation, decreases F for oral drugs